Defining hepatoblastoma responsiveness to induction therapy as measured by tumor volume and serum α-fetoprotein kinetics

Journal of Pediatric Surgery

Volumn 45, Issue 1, 2010, Pages 121-129

  Lovvorn III, Harold N ^a   Ayers, Dan ^a   Zhao, Zhiguo ^a   Hilmes, Melissa ^a   Prasad, Pinki ^a   Shinall Jr , Myrick C ^a   Berch, Barry ^a   Neblett III, Wallace W ^a   O'Neill Jr , James A ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatoblastoma; Serum fetoprotein; Tumor decay; Tumor volume

Indexed keywords

ALPHA FETOPROTEIN; CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; VINCRISTINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; HEPATOBLASTOMA; HUMAN; INFANT; KIDNEY DISEASE; MALE; OTOTOXICITY; PRIORITY JOURNAL; SPEECH DISORDER; TREATMENT RESPONSE; TUMOR VOLUME;

ALPHA-FETOPROTEINS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; FUNCTIONAL LATERALITY; HEPATOBLASTOMA; HUMANS; INFANT; KINETICS; LIVER; LIVER NEOPLASMS; MALE; NEOADJUVANT THERAPY; PREOPERATIVE CARE; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 72649102869     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2009.10.023     Document Type: Article

References (19)

1. Litten J.B., and Tomlinson G.E. Liver tumors in children. Oncologist 13 7 (2008) 812-820
2. Meyers R.L. Tumors of the liver in children. Surg Oncol 16 3 (2007) 195-203
3. Herzog C.E., Andrassy R.J., and Eftekhari F. Childhood cancers: hepatoblastoma. Oncologist 5 6 (2000) 445-453
4. Ortega J.A., Douglass E.C., Feusner J.H., et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18 14 (2000) 2665-2675
5. Evans A.E., Land V.J., Newton W.A., et al. Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 50 5 (1982) 821-826
6. von Schweinitz D., Hecker H., Harms D., et al. Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma-a report from the German Cooperative Pediatric Liver Tumor Study HB-89. J Pediatr Surg 30 6 (1995) 845-852
7. Black C.T., Cangir A., Choroszy M., et al. Marked response to preoperative high-dose cis-platinum in children with unresectable hepatoblastoma. J Pediatr Surg 26 9 (1991) 1070-1073
8. Malogolowkin M.H., Katzenstein H., Krailo M.D., et al. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. J Clin Oncol 24 18 (2006) 2879-2884
9. Malogolowkin M.H., Katzenstein H.M., Krailo M., et al. Redefining the role of doxorubicin for the treatment of children with hepatoblastoma. J Clin Oncol 26 14 (2008) 2379-2383
10. Medary I., Aronson D., Cheung N.K., et al. Kinetics of primary tumor regression with chemotherapy: implications for the timing of surgery. Ann Surg Oncol 3 6 (1996) 521-525
11. Van Tornout J.M., Buckley J.D., Quinn J.J., et al. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group. J Clin Oncol 15 3 (1997) 1190-1197
12. Clericuzio C.L., Chen E., McNeil D.E., et al. Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia. J Pediatr 143 2 (2003) 270-272
13. Trobaugh-Lotrario A.D., Tomlinson G.E., Finegold M.J., et al. Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors. Pediatr Blood Cancer 52 3 (2009) 328-334
14. Schell M.J. The reduced monotonic regression method. J Am Stat Assoc 92 437 (1997) 128-135
15. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria (2008). 3-900051-07-0. http://wwwR-projectorg
16. Dicken B.J., Bigam D.L., and Lees G.M. Association between surgical margins and long-term outcome in advanced hepatoblastoma. J Pediatr Surg 39 5 (2004) 721-725
17. Meyers R.L., Katzenstein H.M., Krailo M., et al. Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma. J Pediatr Surg 42 12 (2007) 2050-2056
18. Austin M.T., Leys C.M., Feurer I.D., et al. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database. J Pediatr Surg 41 1 (2006) 182-186
19. Molmenti E.P., Wilkinson K., Molmenti H., et al. Treatment of unresectable hepatoblastoma with liver transplantation in the pediatric population. Am J Transplant 2 6 (2002) 535-538